Safety Profile and Predictors of Adverse Events of Incadronate Disodium in Treating Breast Cancer Patients with Bone Metastases: A Retrospective Study
Incadronate disodium demonstrates a favorable safety profile for treating bone metastases in breast cancer patients. Identified risk factors, such as prolonged treatment duration and lower hemoglobin levels, highlight the need for intensified dental health management and personalized treatment strategies.
Authors
- Xiuwen Guan
- Wenna Wang (ORCID: https://orcid.org/0000-0002-4492-3718)
- Mingxiao Li (ORCID: https://orcid.org/0000-0002-4150-3080)
- Maiyue He (ORCID: https://orcid.org/0000-0001-8389-879X)
- Mingxia Jiang
- Nilupai Abudureheiyimu
- Qiao Li (ORCID: https://orcid.org/0000-0002-4547-1266)
- Mengqi Zhang (ORCID: https://orcid.org/0000-0003-2090-6320)
- Jiaxuan Liu (ORCID: https://orcid.org/0000-0002-7937-320X)
- Shihan Zhou
- Binghe Xu
- Fei Ma (ORCID: https://orcid.org/0000-0001-8554-7512)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/bctt.s523392
- Citations
- 1
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.05